(Q39268025)

10 September 2017

title

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy (English)

1 reference

10 September 2017

main subject

visceral leishmaniasis

1 reference

1 reference

J Moreno

1

0 references

author name string

J Nieto

2

1 reference

10 September 2017

C Chamizo

3

1 reference

10 September 2017

F González

4

1 reference

10 September 2017

F Blanco

5

1 reference

10 September 2017

D C Barker

6

1 reference

10 September 2017

J Alvar

7

1 reference

10 September 2017

publication date

1 November 1999

1 reference

Veterinary Immunology and Immunopathology

10 September 2017

published in

1 reference

10 September 2017

volume

71

1 reference

10 September 2017

issue

3-4

1 reference

10 September 2017

page(s)

181-195

1 reference

An experimental model for canine visceral leishmaniasis.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Leishmaniasis reservoirs and their significance in control

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Suppression of lymphocyte proliferative responses by sera from patients with American visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Lymphocyte subset abnormalities in canine leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Efficacy and tolerance of an amphotericm B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

The immunology of companion animals: reagents and therapeutic strategies with potential veterinary and human clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Potential role for interleukin-10 in the immunosuppression associated with kala azar

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Immunology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Immunity in kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Gamma delta T cells and the immune response in visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Blood, bone marrow and splenic lymphocyte subset profiles in Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Macrophage‐T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania‐infected macrophages and its implication in the suppression of cell‐mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2899%2900096-3

7 January 2021

10.1016/S0165-2427(99)00096-3

Identifiers

DOI

1 reference

10 September 2017

1 reference